default author photo

Osamu Yamasaki

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

70

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

Efficacy Comparison between Anti-PD-1 Antibody Monotherapy and Anti-PD-1 Plus Anti-CTLA-4 Combination Therapy as First-Line Immunotherapy for Advanced Acral Melanoma: A Retrospective, Multicenter Study of 254 Japanese Patients

Number of pages: 29 Posted: 22 Apr 2022
Saitama Medical University International Medical Center (SIMC) - Department of Skin Oncology/Dermatology, National Cancer Center Hospital, Shinshu University - Department of Dermatology, Nagoya City University, affiliation not provided to SSRN, Shizuoka Cancer Center, Jichi Medical University, affiliation not provided to SSRN, Niigata Cancer Center Hospital, Chiba Cancer Center - Research Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Kawasaki Medical School, affiliation not provided to SSRN, Iwate Medical University, affiliation not provided to SSRN, affiliation not provided to SSRN, Kumamoto Kenhoku Hospital, Kyoto University - Kyoto University Hospital, affiliation not provided to SSRN and National Cancer Center Hospital
Downloads 70 (875,328)
Citation 1

Abstract:

Loading...

acral melanomapalm and solenail apparatusanti-PD-1 antibodyanti-CTLA-4 antibodynivolumabpembrolizumabipilimumab